These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25435884)

  • 61. Review: modulation of the oral microbiome by the host to promote ecological balance.
    Cornejo Ulloa P; van der Veen MH; Krom BP
    Odontology; 2019 Oct; 107(4):437-448. PubMed ID: 30719639
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing.
    Sjöqvist S; Ishikawa T; Shimura D; Kasai Y; Imafuku A; Bou-Ghannam S; Iwata T; Kanai N
    J Extracell Vesicles; 2019; 8(1):1565264. PubMed ID: 30719240
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.
    Brice DC; Toth Z; Diamond G
    Antiviral Res; 2018 Oct; 158():25-33. PubMed ID: 30076864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?
    McCrudden MTC; O'Donnell K; Irwin CR; Lundy FT
    Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30041453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Innate Immunity to Mucosal Candida Infections.
    Verma A; Gaffen SL; Swidergall M
    J Fungi (Basel); 2017 Oct; 3(4):. PubMed ID: 29371576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral microbiome and peri-implant diseases: where are we now?
    Pokrowiecki R; Mielczarek A; Zaręba T; Tyski S
    Ther Clin Risk Manag; 2017; 13():1529-1542. PubMed ID: 29238198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health.
    Khurshid Z; Naseem M; Yahya I Asiri F; Mali M; Sannam Khan R; Sahibzada HA; Zafar MS; Faraz Moin S; Khan E
    Biomolecules; 2017 Dec; 7(4):. PubMed ID: 29206168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fibroblasts: The Unknown Sentinels Eliciting Immune Responses Against Microorganisms.
    Bautista-Hernández LA; Gómez-Olivares JL; Buentello-Volante B; Bautista-de Lucio VM
    Eur J Microbiol Immunol (Bp); 2017 Sep; 7(3):151-157. PubMed ID: 29034104
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients.
    Chhibber-Goel J; Singhal V; Bhowmik D; Vivek R; Parakh N; Bhargava B; Sharma A
    NPJ Biofilms Microbiomes; 2016; 2():7. PubMed ID: 28649401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. β-Defensin-2 is overexpressed in human vocal cord polyps.
    Gu J; Huang Y
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):901-907. PubMed ID: 27586391
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The epithelial cell response to health and disease associated oral biofilm models.
    Ramage G; Lappin DF; Millhouse E; Malcolm J; Jose A; Yang J; Bradshaw DJ; Pratten JR; Culshaw S
    J Periodontal Res; 2017 Jun; 52(3):325-333. PubMed ID: 27330034
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymicrobial Biofilm Studies: From Basic Science to Biofilm Control.
    Willems HM; Xu Z; Peters BM
    Curr Oral Health Rep; 2016 Mar; 3(1):36-44. PubMed ID: 27134811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Oral Microbiome of Denture Wearers Is Influenced by Levels of Natural Dentition.
    O'Donnell LE; Robertson D; Nile CJ; Cross LJ; Riggio M; Sherriff A; Bradshaw D; Lambert M; Malcolm J; Buijs MJ; Zaura E; Crielaard W; Brandt BW; Ramage G
    PLoS One; 2015; 10(9):e0137717. PubMed ID: 26368937
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells.
    Shin JM; Ateia I; Paulus JR; Liu H; Fenno JC; Rickard AH; Kapila YL
    Front Microbiol; 2015; 6():617. PubMed ID: 26150809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial peptides: Defending the mucosal epithelial barrier.
    Johnstone KF; Herzberg MC
    Front Oral Health; 2022; 3():958480. PubMed ID: 35979535
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beta-defensins: what are they really doing in the oral cavity?
    Diamond G; Ryan L
    Oral Dis; 2011 Oct; 17(7):628-35. PubMed ID: 21332602
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The novel antimicrobial peptide beta3-defensin is produced by the amnion: a possible role of the fetal membranes in innate immunity of the amniotic cavity.
    Buhimschi IA; Jabr M; Buhimschi CS; Petkova AP; Weiner CP; Saed GM
    Am J Obstet Gynecol; 2004 Nov; 191(5):1678-87. PubMed ID: 15547542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules.
    Metz-Boutigue MH; Shooshtarizadeh P; Prevost G; Haikel Y; Chich JF
    Curr Pharm Des; 2010; 16(9):1024-39. PubMed ID: 20030614
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epithelial antimicrobial peptides: guardian of the oral cavity.
    Hans M; Madaan Hans V
    Int J Pept; 2014; 2014():370297. PubMed ID: 25435884
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.